Daclizumab
Antibody
Overview
Daclizumab is a antibody active pharmaceutical ingredient (ChEMBL CHEMBL1201605).
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.